A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.
about
Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.Switching from Remicade® to Remsima® is well Tolerated and Feasible: A Prospective, Open-label Study.Optimization of biologic therapy in Crohn's disease.A Rare Adverse Effect of Anti-Tumor Necrosis Factor Alpha Therapy: Sarcoidosis
P2860
A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A safety assessment of anti-tu ...... treatment of Crohn's disease.
@en
type
label
A safety assessment of anti-tu ...... treatment of Crohn's disease.
@en
prefLabel
A safety assessment of anti-tu ...... treatment of Crohn's disease.
@en
P2860
P1476
A safety assessment of anti-tu ...... treatment of Crohn's disease.
@en
P2093
Gerassimos J Mantzaris
Konstantinos Papamichael
P2860
P304
P356
10.1517/14740338.2016.1145653
P407
P577
2016-01-22T00:00:00Z